REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dr.Max 207 S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Accounting, Tax Preparation, Bookkeeping, and Payroll Services
Full name: Dr.Max 207 S.R.O. Profile Updated: July 20, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dr.Max 207 S.R.O. is a company based in Slovakia, with its head office in Kosice. It operates in the Pharmacies and Drug Stores sector. It was first established on September 14, 2005. 10 - 19 (2025) employees currently work for Dr.Max 207 S.R.O.. In 2024, the company reported a net sales revenue increase of 28.64%. Over the same period, its total assets grew by 15.27%. The net profit margin of Dr.Max 207 S.R.O. increased by 1.01% in 2024.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Dr.Max 207 S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Dr.Max 207 S.R.O. report to view the information.
Registered Capital:
Purchase the Dr.Max 207 S.R.O. report to view the information.
Financial Auditors:
Purchase the Dr.Max 207 S.R.O. report to view the information.
Incorporation Date:
September 14, 2005
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dr.Max 207 S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
28.64%▲
Total operating revenue
28.41%▲
Operating profit (EBIT)
143.54%▲
EBITDA
113.63%▲
Net Profit (Loss) for the Period
158.64%▲
Total assets
15.27%▲
Total equity
23.68%▲
Operating Profit Margin (ROS)
1.22%▲
Net Profit Margin
1.01%▲
Return on Equity (ROE)
9.98%▲
Debt to Equity Ratio
-0.67%▼
Quick Ratio
0.16%▲
Cash Ratio
-0.01%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo